J&J eyes solutions

Johnson & Johnson announced last week that it sees a 'significant' opportunity to move into contact lens solutions in the wake of the Fusarium keratitis outbreak linked to Bausch & Lomb's ReNu with MoistureLoc.

Speaking at a J&J medical devices and diagnostic meeting in New Jersey last week, Don Casey, group chairman of J&J's Vistakon eye products unit, said the outbreak presented an opportunity to 'bring real innovation to the category'.

'We believe there is a significant opportunity,' he told analysts. 'We're looking at the market. There are several entry strategies. Obviously we're looking at acquisitions and licensing that would allow us to participate in that market meaningfully,' he said, adding that it would also consider internally developed products.